These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4390900)

  • 1. Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.
    Shin HS; Smith MR; Wood WB
    J Exp Med; 1969 Dec; 130(6):1229-41. PubMed ID: 4390900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat labile opsonins to pneumococcus. I. Participation of complement.
    Smith MR; Wood WB
    J Exp Med; 1969 Dec; 130(6):1209-27. PubMed ID: 4390899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins.
    Smith MR; Shin HS; Wood WB
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1151-6. PubMed ID: 4390986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat labile opsonin system to pneumococcus.
    Shin HS; Smith MR; Winkelstein J; Nicholson A
    Birth Defects Orig Artic Ser; 1975; 11(1):563-6. PubMed ID: 238689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.
    Winkelstein JA; Shin HS; Wood WB
    J Immunol; 1972 Jun; 108(6):1681-9. PubMed ID: 4402312
    [No Abstract]   [Full Text] [Related]  

  • 7. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of complement in the localization of pneumococci in the splanchnic reticuloendothelial system during experimental bacteremia.
    Brown EJ; Hosea SW; Frank MM
    J Immunol; 1981 Jun; 126(6):2230-5. PubMed ID: 7229372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of opsonins in recovery from experimental pneumococcal pneumonia.
    Guckian JC; Christensen GD; Fine DP
    J Infect Dis; 1980 Aug; 142(2):175-90. PubMed ID: 6997403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of C3 as an opsonin in the early stages of infection.
    Winkelstein JA; Smith MR; Shin HS
    Proc Soc Exp Biol Med; 1975 Jun; 149(2):397-401. PubMed ID: 1153415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
    Hostetter MK; Krueger RA; Schmeling DJ
    J Infect Dis; 1984 Nov; 150(5):653-61. PubMed ID: 6491376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.
    Brown EJ; Joiner KA; Cole RM; Berger M
    Infect Immun; 1983 Jan; 39(1):403-9. PubMed ID: 6822421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for quantitative variability of bacterial opsonic requirements.
    Guckian JC; Christensen WD; Fine DP
    Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonin.
    Stossel TP
    J Cell Biol; 1973 Aug; 58(2):346-56. PubMed ID: 4738105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.
    Brown EJ; Hosea SW; Frank MM
    Rev Infect Dis; 1983; 5 Suppl 4():S797-805. PubMed ID: 6356294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae.
    Coonrod JD; Yoneda K
    Rev Infect Dis; 1981; 3(2):310-22. PubMed ID: 7256089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.